1,557
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Mediating effect of subclinical inflammation on the process of morning hypertension leading to atrial fibrillation in community-based older adults

ORCID Icon, , , , , , , , & show all
Article: 2253381 | Received 05 Jul 2023, Accepted 24 Aug 2023, Published online: 31 Aug 2023

References

  • Morin DP, Bernard ML, Madias C, Rogers PA, Thihalolipavan S, Estes NA 3rd. The state of the art: atrial fibrillation epidemiology, prevention, and treatment. Mayo Clin Proc. 2016;91(12):1778–10. doi:10.1016/j.mayocp.2016.08.022.
  • No authors listed. Atrial fibrillation. Nat Rev Dis Primers. 2022, 8 (1), 20. doi:10.1038/s41572-022-00354-w.
  • Baman JR, Passman RS. Atrial fibrillation. JAMA. 2021;325(21):2218. doi:10.1001/jama.2020.23700.
  • Zimetbaum P. Atrial fibrillation. Ann Intern Med. 2017;166(5):ITC33–48. doi:10.7326/AITC201703070.
  • Watanabe H, Kabutoya T, Hoshide S, Kario K. Atrial fibrillation is associated with cardiovascular events in obese Japanese with one or more cardiovascular risk factors: the Japan morning surge home blood pressure (J-HOP) study. J Clin Hypertens. 2021;23(3):665–71. doi:10.1111/jch.14170.
  • Kallistratos MS, Poulimenos LE, Manolis AJ. Atrial fibrillation and arterial hypertension. Pharmacol Res. 2018;128:322–26. doi:10.1016/j.phrs.2017.10.007.
  • Steinberg JS, Shabanov V, Ponomarev D, Losik D, Ivanickiy E, Kropotkin E, Polyakov K, Ptaszynski P, Keweloh B, Yao CJ, et al. Effect of renal denervation and catheter ablation vs catheter ablation alone on atrial fibrillation recurrence among patients with paroxysmal atrial fibrillation and hypertension: the ERADICATE-AF randomized clinical trial. JAMA. 2020;323(3):248–55. doi:10.1001/jama.2019.21187.
  • Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heibuchel H, Hendriks J, et al. ESC Scientific Document Group. ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–962. doi:10.1093/eurheartj/ehw210.
  • Yang Y, He K, Zhang Y, Wu X, Chen W, Gu D, Zeng Z. Ethnicity disparities in the prevalence, awareness, treatment, and control rates of hypertension in China. Int J Hypertens. 2023;2023:1432727. doi:10.1155/2023/1432727.
  • Redfern A, Peters SAE, Luo R, Cheng Y, Li C, Wang J, Anderson C, Wang H, Norton R. Sex differences in the awareness, treatment, and control of hypertension in China: a systematic review with meta-analyses. Hypertens Res. 2019;42(2):273–83. doi:10.1038/s41440-018-0154-x.
  • Kario K, Hasebe N, Okumura K, Yamashita T, Akao M, Atarashi H, Ikeda T, Koretsune Y, Shimizu W, Tsutsui H, et al. High prevalence of masked uncontrolled morning hypertension in elderly non-valvular atrial fibrillation patients: home blood pressure substudy of the ANAFIE registry. J Clin Hypertens. 2021;23(1):73–82. doi:10.1111/jch.14095
  • Kario K, Wang JG, Chia YC, Wang TD, Li Y, Siddique S, Shin J, Turana Y, Buranakitjaroen P, Chen CH, et al. The HOPE Asia network 2022 up-date consensus statement on morning hypertension management. J Clin Hypertens. 2022;24(9):1112–20. doi:10.1111/jch.14555
  • Kario K. IClinician’s manual on early morning risk management in hypertension. London, UK: Science Press; 2004. 1–68p.
  • Kario K. Time for focus on morning hypertension: pitfall of current antihypertensive medication. Am J Hypertens. 2005;18(2 Pt 1):149–51. doi:10.1016/j.amjhyper.2004.09.007.
  • Taş Ü, Taş S, Yavuz İ. The relationship between morning blood pressure surge and asymptomatic episodes of paroxysmal atrial fibrillation in patients with systemic arterial hypertension. Turk J Med Sci. 2022;52(6):1906–16. doi:10.55730/1300-0144.5538.
  • Marfella R, Gualdiero P, Siniscalchi M, Carusone C, Verza M, Marzano S, Esposito K, Giugliano D. Morning blood pressure peak, QT intervals, and sympathetic activity in hypertensive patients. Hypertension. 2003;41(2):237–3. doi:10.1161/01.hyp.0000050651.96345.0e.
  • Nakagami H, Akiyama H, Otsuka H, Takahashi SA, Sawada K, Kobayashi N, Iwanae A, Yamada H. Morning surge in sympathetic nervous activity in the indoor environment during the cold winter season. Hypertens Res. 2023;46(1):231–35. doi:10.1038/s41440-022-01020-0.
  • Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–43. doi:10.1038/nrcardio.2015.2.
  • Saylik F, Sarıkaya R. Can systemic immune-inflammation index detect the presence of exaggerated morning blood pressure surge in newly diagnosed treatment-naive hypertensive patients? Clin Exp Hypertens. 2021;43(8):772–79. doi:10.1080/10641963.2021.1960366.
  • Yang X, Zhao S, Wang S, Cao X, Xu Y, Yan M, Pang M, Yi F, Wang H. Systemic inflammation indicators and risk of incident arrhythmias in 478,524 individuals: evidence from the UK Biobank cohort. BMC Med. 2023;21(1):76. doi:10.1186/s12916-023-02770-5.
  • Liu Z, Zhao Y, Wei F, Ye L, Lu F, Zhang H, Diao Y, Song H, Qi Z. Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis. Atherosclerosis. 2014;233(1):291–99. doi:10.1016/j.atherosclerosis.2013.12.004.
  • Nogueira-Ferreira R, Sousa-Nunes F, Leite-Moreira A, Moreira-Costa L, Vitorino R, Lara Santos L, Moreira-Gonçalves D, Ferreira R. Cancer- and cardiac-induced cachexia: same fate through different inflammatory mediators? Inflamm Res. 2022;71(7–8):771–83. doi:10.1007/s00011-022-01586-y.
  • Liu ZD, Wang L, Lu FH, Pan H, Zhao YX, Wang SJ, Sun SW, Li CL, Hu XL. Increased Th17 cell frequency concomitant with decreased Foxp3+ Treg cell frequency in the peripheral circulation of patients with carotid artery plaques. Inflamm Res. 2012;61(10):1155–65. doi:10.1007/s00011-012-0510-2.
  • Li K, Song H, Wei F, Liu D, Zhao Y, Yin H, Cui Y, Zhang H, Liu Z. High salt intake damages myocardial viability and induces cardiac remodeling via chronic inflammation in the elderly. Front Cardiovasc Med. 2022;9:952691. doi:10.3389/fcvm.2022.952691.
  • Cheng WL, Chen YC, Li SJ, Lee TI, Lee TW, Higa S, Chung CC, Kao YH, Chen SA, Chen YJ. Galectin-3 enhances atrial remodelling and arrhythmogenesis through CD98 signalling. Acta Physiol (Oxf). 2022;234(3):e13784. doi:10.1111/apha.13784.
  • Simu GR, Tomoaia R, Rosu RO, Gusetu G, Puiu M, Cismaru G, Caloian B, Terec A, Buliga T, Boer A, et al. Galectin-3, inflammation, and the risk of atrial high-rate episodes in patients with dual chamber pacemakers. Int J Mol Sci. 2023;24(9):7710. doi:10.3390/ijms24097710
  • Zhang H, Cui Y, Zhao Y, Dong Y, Wang J, Duan D, Ji T, Zhou T, Hu W, Chen Y, et al. Association of circadian rhythm of blood pressure and cerebral small vessel disease in community-based elderly population. J Gerontol A Biol Sci Med Sci. 2019;74(8):1322–30. doi:10.1093/gerona/gly212.
  • European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability, Parati G, Stergiou G, O’Brien E, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P. European society of hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014;32(7)1359–66. 10.1097/HJH.0000000000000221.
  • Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. Circadian rhythms and cardiovascular health. Sleep Med Rev. 2012;16(2):151–66. doi:10.1016/j.smrv.2011.04.003.
  • Kishimoto A, Tochikubo O, Ohshige K. Relation between nocturnal arterial oxygen desaturation and morning blood pressure. Clin Exp Hypertens. 2007;29(1):51–60. doi:10.1080/10641960601096786.
  • Kario K. Essential Manual of 24-hour blood pressure management. 2nd. Wiley; 2022. 1–374 p. 10.1002/9781119799412
  • Kario K, Yano Y, Matsuo T, Hoshide S, Eguchi K, Shimada K. Additional impact of morning haemostatic risk factors and morning blood pressure surge on stroke risk in older Japanese hypertensive patients. Eur Heart J. 2011;32(5):574–80. doi:10.1093/eurheartj/ehq444.
  • Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J. Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study. Hypertension. 2012;59(2):198–204. doi:10.1161/HYPERTENSIONAHA.111.179713.
  • Kabutoya T, Ohmori T, Fujiwara T, Kario K. Combination therapy with an Xa inhibitor and antihypertensive agent improved anticoagulant activity in patients with nonvalvular atrial fibrillation: the hypertension and atrial fibrillation treated by rivaroxaban for the morning and night with sYnergy with calcium antagonists (HARMONY) study. Clin Exp Hypertens. 2020;42(4):365–70. doi:10.1080/10641963.2019.1665678.
  • Hoshide S, Tomitani N, Kario K. Maximum ambulatory daytime blood pressure and risk of stroke in individuals with higher ambulatory arterial stiffness index: the JAMP study. Hypertens Res. 2023;46(1):84–90. doi:10.1038/s41440-022-01048-2.
  • Omboni S, Ballatore T, Rizzi F, Tomassini F, Campolo L, Panzeri E, Kristina L, Kahan T. 24-hour ambulatory blood pressure telemonitoring in patients at risk of atrial fibrillation: results from the TEMPLAR project. Hypertens Res. 2022;45(9):1486–95. doi:10.1038/s41440-022-00932-1.
  • Wang JG, Kario K, Park JB, Chen CH. Morning blood pressure monitoring in the management of hypertension. J Hypertens. 2017;35(8):1554–63. doi:10.1097/HJH.0000000000001379.
  • Fashanu OE, Norby FL, Aguilar D, Ballantyne CM, Hoogeveen RC, Chen LY, Soliman EZ, Alonso A, Folsom AR. Galectin-3 and incidence of atrial fibrillation: The atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2017;192:19–25. doi:10.1016/j.ahj.2017.07.001.
  • Hoshide S, Kario K, de la Sierra A, Bilo G, Schillaci G, Banegas JR, Gorostidi M, Segura J, Lombardi C, Omboni S, et al. Ethnic differences in the degree of morning blood pressure surge and in its determinants between Japanese and European hypertensive subjects: data from the ARTEMIS study. Hypertension. 2015;66(4):750–56. doi:10.1161/HYPERTENSIONAHA.115.05958
  • Roselli C, Chaffin MD, Weng LC, Aeschbacher S, Ahlberg G, Albert CM, Almgren P, Alonso A, Anderson CD, Aragam KG, et al. Multi-ethnic genome-wide association study for atrial fibrillation. Nat Genet. 2018;50(9):1225–33. doi:10.1038/s41588-018-0133-9.
  • Norby FL, Benjamin EJ, Alonso A, Chugh SS. Racial and ethnic considerations in patients with atrial fibrillation: JACC focus seminar 5/9. J Am Coll Cardiol. 2021;78(25):2563–72. doi:10.1016/j.jacc.2021.04.110.
  • Essien UR, Kornej J, Johnson AE, Schulson LB, Benjamin EJ, Magnani JW. Social determinants of atrial fibrillation. Nat Rev Cardiol. 2021;18(11):763–73. doi:10.1038/s41569-021-00561-0.
  • Shulman E, Kargoli F, Aagaard P, Hoch E, Di Biase L, Fisher J, Gross J, Kim S, Ferrick KJ, Krumerman A. Socioeconomic status and the development of atrial fibrillation in Hispanics, African Americans and non-Hispanic whites. Clin Cardiol. 2017;40(9):770–76. doi:10.1002/clc.22732.
  • Mou L, Norby FL, Chen LY, O’Neal WT, Lewis TT, Loehr LR, Soliman EZ, Alonso A. Lifetime risk of atrial fibrillation by race and socioeconomic status: ARIC study (atherosclerosis risk in communities). Circ Arrhythm Electrophysiol. 2018;11(7):e006350. doi:10.1161/CIRCEP.118.006350.